Literature DB >> 9746989

[Laparoscopic versus conventional appendectomy--a comparison with reference to early postoperative complications].

S Barkhausen1, C Wullstein, E Gross.   

Abstract

OBJECTIVE AND METHODS: To compare the complications of laparoscopic appendectomy (LA) and conventional appendectomy (CA) 930 consecutive patients from 1989 until 1997 were analysed retrospectively.
RESULTS: Conventional appendectomy was performed in 330 patients, laparoscopic in 554 patients and another 46 patients required conversion after laparoscopy. The groups were similar in sex ratio, age and degree of inflammation. Postoperative complications occurred in 8.78%. There were less complications in the LA-group (4.69%) than in the CA-group (13.33%) (p < 0.01), especially wound infections were found less in the LA-group (1.8% vs. 11.21%, p < 0.01). The incidence of intraabdominal abscesses was similar in the LA and CA group (1.44% vs. 1.52%). The differences between the groups are not influenced by complicating appendicitis (perforation or abscess). Systemic complications were similar for LA and CA (0.72% and 0.61%), but were seen more often after conversion (6.52%, p < 0.01).
CONCLUSIONS: This retrospective analysis shows that laparoscopic appendectomy significantly reduces postoperative complications, especially wound infections. The authors consider laparoscopic appendectomy to be the procedure of choice in patients with acute appendicitis.

Entities:  

Mesh:

Year:  1998        PMID: 9746989

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  A prospective, randomized, unicenter study comparing laparoscopic and open treatments of acute appendicitis.

Authors:  M Milewczyk; M Michalik; M Ciesielski
Journal:  Surg Endosc       Date:  2003-05-06       Impact factor: 4.584

2.  Laparoscopic appendectomy using a polymeric clip to close the appendicular stump.

Authors:  Andrés Hanssen; Sergio Plotnikov; Rinci Dubois
Journal:  JSLS       Date:  2007 Jan-Mar       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.